Ellis J. Neufeld, MD, PhD, has been appointed Clinical Director, Physician-in-Chief, and Executive Vice President of St. Jude Children’s Research Hospital.
Dr. Neufeld’s appointment will begin in March 2017. In this role, Dr. Neufeld will oversee the organization’s academic clinical departments and all clinical operations. The appointment comes as St. Jude launches a focused effort to increase the number of patients with cancer treated at its campus and on its protocols around the world.
An internationally respected leader in pediatric hematology, Dr. Neufeld comes to St. Jude from Harvard Medical School, where he served on the faculty for the past 26 years. He was most recently Associate Chief of the Division of Hematology/Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dr. Neufeld was also Medical Director at the Boston Hemophilia Center and held the Egan Family Foundation Chair in Transitional Medicine at Harvard Medical School as a Professor of Pediatrics.Error loading Partial View script (file: ~/Views/MacroPartials/TAP Article Portrait Widget.cshtml)
“Dr. Neufeld’s leadership and experience will help steer St. Jude clinical operations as we expand our patient care programs, increase the number of patients treated, and work to set the standard for pediatric cancer care delivery,” said James R. Downing, MD, St. Jude President and Chief Executive Officer.
Dr. Neufeld earned his doctoral degrees at Washington University in St. Louis. He then completed specialty training in pediatrics and medical genetics at Boston Children’s Hospital and in pediatric hematology/oncology at Dana-Farber Cancer Institute and Boston Children’s Hospital. He has worked as a physician-scientist in the laboratory and as a clinical researcher in nonmalignant hematology, with numerous publications in the areas of hemophilia, thalassemia, and immune thrombocytopenia. ■